Jacobs Levy Equity Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,404
Closed -$227K 1078
2024
Q2
$227K Sell
8,404
-402,968
-98% -$8.38M ﹤0.01% 911
2024
Q1
$7.54M Buy
411,372
+328,404
+396% +$5.21M 0.03% 349
2023
Q4
$1.02M Buy
+82,968
New +$778K 0.01% 715

Other funds holding SILK

Jacobs Levy Equity Management's SILK Position: Q3 2024 in Review

Jacobs Levy Equity Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 8,404 shares — an estimated $227K sold.

Jacobs Levy Equity Management first reported a position in SILK in Q4 2023 and held it in 3 quarters. The position peaked at $7.54M in Q1 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Jacobs Levy Equity Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 8,404 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $227K.
  • Jacobs Levy Equity Management first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • Jacobs Levy Equity Management's Silk Road Medical, Inc. Common Stock position peaked at $7.54M in Q1 2024.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2024, filed 14 Nov 2024.